Key Takeaways
- Bank of America lowered Nestlé’s rating from Buy to Neutral, reducing the price target from CHF 94 to CHF 89
- Shares of the Swiss food giant declined 1.8% in Zurich trading after the analyst action
- The company’s North American Petcare business, representing approximately 13% of total revenue, is experiencing market share declines in both feline and canine food segments
- Commodity headwinds intensified with cocoa prices surging nearly 70% and coffee climbing 15% since April
- First-half 2024 results revealed a ~31% decline in bottom-line profit driven by impairment charges
Shares of Nestlé retreated 1.8% in Swiss trading on Monday following Bank of America Securities’ decision to downgrade the stock from Buy to Neutral while trimming its price objective to CHF 89 from CHF 94.
At the time of the rating change, shares were changing hands near CHF 79.23.
The analyst action arrives on the heels of Nestlé’s July 23 first-half earnings release, which revealed net income tumbling approximately 31% as a result of impairment charges.
In their research note, BofA analysts under the direction of Nicolas Ceron identified North American Petcare operations as the primary concern. This division represents roughly 13% of the company’s consolidated revenue — making it the largest single category-region pairing.
According to the firm’s analysis, Nestlé is experiencing deteriorating positions in both the feline and canine food markets. The challenges in dog food appear particularly entrenched, stemming from consumer migration toward fresh and premium product formats.
Today, every significant competitor in the Petcare space has introduced fresh product lines — with the notable exception of Nestlé. Following Colgate’s recent market entry, Purina stands alone among leading brands without a fresh offering.
The fresh pet food segment currently accounts for just 10% of the total market yet drives 100% of category expansion. This represents a strategic vulnerability Nestlé cannot afford to overlook.
Cost Pressures Intensify
Addressing this competitive deficit will require substantial capital. BofA calculates that accelerating Petcare volume expansion from the current 2.5% trajectory to a 3–4% range would necessitate significant investment in a division already burdened with considerably higher supply-chain expenses.
Freshpet, the dominant player in refrigerated pet nutrition in the United States, operates with profitability margins running 1,000 basis points below those of Nestlé’s Petcare operations — illustrating the economic challenges inherent in the fresh category.
Simultaneously, two critical raw material categories are moving unfavorably. Coffee quotations have advanced 15% while cocoa has skyrocketed nearly 70% since BofA resumed coverage in April.
Consequently, the gross profitability improvement BofA had previously anticipated from declining input expenses has contracted to approximately 240 basis points for 2026–27, down from roughly 370 basis points projected in April.
The firm reduced its 2027 operating margin projection by 20 basis points and lowered earnings per share estimates for 2027–28 by 1% and 2% respectively.
Industry-Wide Canine Food Challenges
On the same day, BofA also downgraded Freshpet to Neutral, citing widespread weakness in dog food category expansion. This parallel action indicates the challenges extend beyond Nestlé alone.
Across North America, canine food volume and mix growth currently registers at negative 0.5%, according to BofA’s calculations.
Nestlé’s current valuation stands at 14.6 times 2026 enterprise value to EBIT — representing a 3% premium relative to European Food and Household/Personal Care comparables. BofA contends this “fairly reflects” anticipated EBIT expansion through 2028.
The broader Swiss Market Index showed no adverse macroeconomic signals during the session, confirming the selloff was company-specific rather than market-driven.
With the S&P 500 advancing 1.0% and the Nasdaq climbing 1.6% on the same trading day, Nestlé’s decline represented a distinct case of idiosyncratic equity pressure.
BofA’s updated price objective maintains an unchanged 3.9% weighted average cost of capital but incorporates a reduced terminal growth rate of -1.0%, acknowledging “diminished expansion prospects in North American Petcare.”





